ULIHF (United Laboratories International Holdings) Other Current Payables: $414 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ULIHF United Laboratories International Holdings Ltd ULIHF
80 GF Score
Price $1.24
GF Value $1.42
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings Other Current Payables?

United Laboratories International Holdings ULIHF 80 Other Current Payables is $414 Mil as of Dec. 2025. GuruFocus rates ULIHF with a GF Score™ of 80/100 and a GF Value™ of $1.42 (Modestly Undervalued). The stock has 5 warning signs investors should review.

United Laboratories International Holdings's Other Current Payables for the quarter that ended in Dec. 2025 was $414 Mil.

United Laboratories International Holdings's quarterly Other Current Payables declined from Dec. 2024 ($319 Mil) to Jun. 2025 ($101 Mil) but then increased from Jun. 2025 ($101 Mil) to Dec. 2025 ($414 Mil).

United Laboratories International Holdings's annual Other Current Payables increased from Dec. 2023 ($141 Mil) to Dec. 2024 ($319 Mil) and increased from Dec. 2024 ($319 Mil) to Dec. 2025 ($414 Mil).

United Laboratories International Holdings Other Current Payables Related Terms

United Laboratories International Holdings Other Current Payables Historical Data

* Premium members only.

The historical data trend for United Laboratories International Holdings's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Laboratories International Holdings Other Current Payables Chart

United Laboratories International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 119.37 130.49 141.33 319.32 413.85

United Laboratories International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.33 231.76 319.32 101.22 413.85
ULIHF
80GF Score
United Laboratories International Holdings Ltd ULIHF
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Laboratories International Holdings Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $414 Mil mean?
United Laboratories International Holdings (ULIHF) has a Other Current Payables of $414 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on United Laboratories International Holdings and its competitors.
Is United Laboratories International Holdings' Other Current Payables too high?
United Laboratories International Holdings' current Other Current Payables is $414 Mil. Overall, United Laboratories International Holdings has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' Other Current Payables compare to ZTS?
United Laboratories International Holdings' Other Current Payables of $414 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on United Laboratories International Holdings and its competitors. United Laboratories International Holdings's current Other Current Payables is $414 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
Based on GuruFocus' analysis, United Laboratories International Holdings (ULIHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.42, compared to a current price of $1.24 — trading 12.7% below its estimated fair value. The current Other Current Payables is $414 Mil. United Laboratories International Holdings' overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For United Laboratories International Holdings (ULIHF), the current Other Current Payables is $414 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Laboratories International Holdings (ULIHF) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be undervalued. The current stock price of $1.24 is trading 12.7% below its estimated GF Value™ of $1.42. GuruFocus considers United Laboratories International Holdings to be Modestly Undervalued.

Key valuation signals for ULIHF:

  • Other Current Payables: $414 Mil
  • GF Value™: $1.42 vs. price of $1.24 (12.7% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the ULIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

United Laboratories International Holdings Business Description

Other Exchanges 03933:Hong KongUNJ:Germany
Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
80GF Score

Get the complete analysis for ULIHF

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.24
Price
$1.42
GF Value